InvestorsHub Logo
Followers 22
Posts 3646
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Thursday, 02/08/2007 10:37:05 AM

Thursday, February 08, 2007 10:37:05 AM

Post# of 19309
Read Me First - Patent Applications Update -

1 METHOD OF PURIFYING RECOMBINANT HUMAN ANTITHROMBIN TO ENHANCE THE VIRAL AND PRION SAFETY PROFILE
Inventor: ZIOMEK CAROL (US); HENDRY CHRISTOPHER (US) Applicant: GTC BIOTHERAPEUTICS INC (US); ZIOMEK CAROL (US); (+1)
EC: IPC: C07K14/81; G01N33/50; C07K14/81 (+1)
Publication info: WO2007014244 - 2007-02-01
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007014244&F=0

2 ERYTHROPOIETIN ANALOG-HUMAN SERUM ALBUMIN FUSION
Inventor: YOUNG MICHAEL W (US); MEADE HARRY M (US); (+1) Applicant: GTC BIOTHERAPEUTICS INC (US)
EC: C07K14/505; C07K14/765 IPC: A01K67/027; C12N15/62; A61K31/70 (+30)
Publication info: DK1088084T - 2007-01-29
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=DK1088084T&F=0

3 METHOD OF MAKING RECOMBINANT HUMAN ANTIBODIES FOR USE IN BIOSENSOR TECHNOLOGY Inventor: LIPOSKY GREGORY (US); OLSEN BYRON (US) Applicant: GTC BIOTHERAPEUTICS INC (US); LIPOSKY GREGORY (US); (+1)
EC: IPC: G01N33/53; C12P21/08; G01N33/53 (+1)
Publication info: WO2007001264 - 2007-01-04
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007001264&F=0

4 METHOD OF MAKING RECOMBINANT HUMAN ANTIBODIES FOR USE IN BIOSENSOR TECHNOLOGY
Inventor: LIPOSKY GREGORY (US); OLSEN BYRON V (US) Applicant: GTC BIOTHERAPEUTICS INC (US); LIPOSKY GREGORY (US); (+1)
EC: IPC: G01N33/50; G01N33/50
Publication info: WO2006138647 - 2006-12-28
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2006138647&F=0

5 METHODS OF PROTEIN FRACTIONATION USING HIGH PERFORMANCE TANGENTIAL FLOW FILTRATION Inventor: PERRAULT MARK (US) Applicant: GTC BIOTHERAPEUTICS INC (US)
EC: IPC: A61K38/17; C07K1/34; A61K38/17 (+1)
Publication info: EP1732587 - 2006-12-20
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1732587&F=0

6 METHOD OF PREVENTING FIBRIN CLOTS IN PULMONARY TISSUE THROUGH THE USE OF AEROSOLIZED ANTICOAGULANTS
Inventor: ENKHBAATAR PERENLEI (US); TRABER DANIEL L (US); (+1) Applicant: GTC BIOTHERAPEUTICS INC (US)
EC: A61K31/727; A61K38/36; (+1) IPC: A61K38/55; A61K31/727; A61K38/36 (+3)
Publication info: CA2557411 - 2005-09-09
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=CA2557411&F=0

7 USE OF AEROSOLIZED ANTITHROMBIN TO TREAT ACUTE LUNG INJURY Inventor: MURAKAMI KAZUNORI (US); ENKHBAATAR PERENLEI (US); (+4) Applicant: GTC BIOTHERAPEUTICS INC (US)
EC: A61K38/57 IPC: A61K38/48; A61K38/57; A61L9/04 (+3)
Publication info: EP1713500 - 2006-10-25
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1713500&F=0

8 Improved methods for the fusion and activation of reconstructed embryos for use in nuclear transfer procedures in non-human mammals
Inventor: GAVIN WILLIAM G; MELICAN DAVID; (+1) Applicant: GTC BIOTHERAPEUTICS INC
EC: C12N15/87C1 IPC: A01K67/027; A61L27/00; C12N5/10 (+9)
Publication info: NZ533692 - 2006-09-29
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=NZ533692&F=0

9 A METHOD OF USING AN ANTI-CD137 ANTIBODY AS AN AGENT FOR RADIOIMMUNOTHERAPY OR RADIOIMMUNODETECTION
Inventor: STROME SCOTT E (US); SCHINDLER DANIEL (US); (+3) Applicant: GTC BIOTHERAPEUTICS INC (US); STROME SCOTT E (US); (+4)
EC: IPC: A61K39/395; C07K16/30; A61K39/395 (+1)
Publication info: WO2006088464 - 2006-08-24
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2006088464&F=0

10 AN ANTI-CD137 ANTIBODY AS AN AGENT IN THE TREATEMENT OF CANCER AND GLYCOSYLATION VARIANTS THEREOF
Inventor: STROME SCOTT E (US); SCHINDLER DANIEL (US); (+2) Applicant: GTC BIOTHERAPEUTICS INC (US); STROME SCOTT E (US); (+3)
EC: IPC: C07K16/00; A61K39/395; C12P21/00 (+3)
Publication info: WO2006088447 - 2006-08-24
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2006088447&F=0


Intellectual property - Thanks to Dew:

#msg-9174865 Production (“milk”) patent
#msg-7179529 Purification patent
#msg-13154218 Nuclear-transfer IP from Geron
#msg-4107224 IP license to PharmAthene (formerly Nexia) for Protexia
#msg-14110344 Government grant for Protexia



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.